Search Log In

fig1

From:  Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease
Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease

Figure 1. Schematic diagram of the molecular mechanisms of the plasminogen activator system. PAI-1: Plasminogen activator inhibitor-1; NSP: neuroserpin; uPA: urokinase-type plasminogen activator; tPA: tissue-type plasminogen activator; PLG: plasminogen; PLM: plasmin. Created with BioRender.com.

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties